Olivier Roux

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

Christophe Corpechot, Olivier Chazouillères, Alexandra Rousseau et al. · New England Journal of Medicine · 2018 · 611 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial

Elisa Pose, Laura Napoleone, Ahmed Adel Amin et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 145 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis

Julien Bissonnette, José Altamirano, Cécile Devue et al. · Hepatology · 2017 · 115 citations

Medicine, Immunology, Pathology +17

Hypervirulent<i>Klebsiella pneumoniae</i>in Cryptogenic Liver Abscesses, Paris, France

Benjamín Rossi, Maria Ludovica Gasperini, Véronique Leflon‐Guibout et al. · Emerging infectious diseases · 2018 · 87 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult‐to‐treat primary biliary cholangitis

Pierre‐Antoine Soret, Laurent Lam, Fabrice Carrat et al. · Alimentary Pharmacology & Therapeutics · 2021 · 74 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17